Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1

The functional role of nuclear factor of activated T-cells (NFAT), a key regulator of the immune response, in bladder cancer progression remains uncertain. In this study, we assessed biological significance of NFAT in human bladder cancer. Immunohistochemistry detected nuclear/cytoplasmic NFATc1 sig...

Full description

Saved in:
Bibliographic Details
Published inOncotarget Vol. 6; no. 3; pp. 1582 - 1593
Main Authors Kawahara, Takashi, Kashiwagi, Eiji, Ide, Hiroki, Li, Yi, Zheng, Yichun, Miyamoto, Yurina, Netto, George J, Ishiguro, Hitoshi, Miyamoto, Hiroshi
Format Journal Article
LanguageEnglish
Published United States Impact Journals LLC 30.01.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The functional role of nuclear factor of activated T-cells (NFAT), a key regulator of the immune response, in bladder cancer progression remains uncertain. In this study, we assessed biological significance of NFAT in human bladder cancer. Immunohistochemistry detected nuclear/cytoplasmic NFATc1 signals in 14 (21.5%)/34 (52.3%), respectively, of 65 muscle-invasive bladder carcinomas and showed that patients with nuclear NFATc1-positive tumor had a significantly higher risk of disease progression (P = 0.006). In bladder cancer cell lines, cyclosporine A (CsA) and tacrolimus (FK506), immunosuppressant drugs/non-selective NFAT inhibitors, attenuated NFATc1 expression and its nuclear translocation, NFAT transcriptional activity, and the expression of cyclooxygenase-2 and c-myc, downstream targets of NFATc1. NFAT inhibition via NFATc1-small interfering RNA (siRNA) or treatment with these NFAT inhibitors resulted in decreases in cell viability/colony formation, cell migration/invasion, and the expression/activity of MMP-2 and MMP-9, as well as an increase in apoptosis, in the parental/control lines. No significant additional inhibition in the viability and invasion of NFATc1-siRNA cells was seen. In xenograft-bearing mice, CsA and FK506 significantly retarded tumor growth. These results suggest that NFATc1 plays an important role in bladder cancer outgrowth. Thus, NFATc1 inactivation, especially using CsA and FK506, has the potential of being a therapeutic approach for bladder cancer.
ISSN:1949-2553
1949-2553
DOI:10.18632/oncotarget.2750